Accès gratuit
Numéro
Med Sci (Paris)
Volume 18, Numéro 3, Mars 2002
Page(s) 353 - 356
Section M/S Revues : Mini-Synthèses
DOI https://doi.org/10.1051/medsci/2002183353
Publié en ligne 15 mars 2002
  1. Consensus statement. EASL International Consensus Conference on Hepatitis C. J Hepatol 1999; 30 : 956–61.
  2. Cadranel JF, Rufat P, Degos F. Practices of liver biopsy in France: results of a prospective nationwide survey. Hepatology 2000; 32 : 477–81.
  3. Rayssiguier R, Bonny C, Abergel A, et al. Pratiques et attentes des médecins généralistes en matière d’hépatite C dans la région Auvergne. Gastroenterol Clin Biol 2001; 25 : A67 (abstract).
  4. Poynard T, Ratziu V, Bedossa P. Appropriateness of liver biopsy. Can J Gastroenterol 2000; 14 : 543–8.
  5. Imbert-Bismut F, Ratziu V, Pieroni L, et al. Biochemical markers of liver fibrosis in patients with hepatitis C virus infection : a prospective study. Lancet 2001; 357 : 1069–75.
  6. Guechot J, Laudat A, Loria A, Serfaty L, Poupon R, Giboudeau J. Diagnostic accuracy of hyaluronan and type III procollagen amino-terminal peptide serum assays as markers of liver fibrosis in chronic viral hepatitis C evaluated by ROC curve analysis. Clin Chem 1996; 42 : 558–63.
  7. Oberti F, Valsesia E, Pilette C, et al. Noninvasive diagnosis of hepatic fibrosis or cirrhosis. Gastroenterology 1997; 113 : 1609–16.
  8. Tiggelman AM, Boers W, Moorman AF, et al. Localization of alpha 2-macroglobulin protein and messenger RNA in rat liver fibrosis: evidence for the synthesis of alpha 2-macroglobulin within Schistosoma mansoni egg granulomas. Hepatology 1996; 23 : 1260–7.
  9. Tiggelman AM, Linthorst C, Boers W, Brand HS, Chamuleau RA. Transforming growth factorbeta-induced collagen synthesis by human liver myofibroblasts is inhibited by alpha2-macroglobulin. J Hepatol 1997; 26 : 1220–8.
  10. Naveau S, Poynard T, Benattar C, Bedossa P, Chaput JC. Alpha-2-macroglobulin and hepatic fibrosis. Diagnostic interest. Dig Dis Sci 1994; 39 : 2426–32.
  11. Meisse D, Renouf S, Husson A, Lavoinne A. Cell swelling increased the alpha2-macroglobulin gene expression in cultured rat hepatocytes. FEBS Lett 1998; 422 : 346–8.
  12. Kawser CA, Iredale JP, Winwood PJ, Arthur MJ. Rat hepatic stellate cell expression of alpha2-macroglobulin is a feature of cellular activation: implications for matrix remodelling in hepatic fibrosis. Clin Sci 1998; 95 : 179–86.
  13. Bacq Y, Schillio Y, Brechot JF, De Muret A, Dubois F, Metman EH. Decrease of haptoglobin serum level in patients with chronic viral hepatitis C. Gastroenterol Clin Biol 1993; 17 : 364–9.
  14. Louagie HK, Brouwer JT, Delanghe JR, De Buyzere ML, Leroux-Roels GG. Haptoglobin polymorphism and chronic hepatitis C. J Hepatol 1996; 25 : 10–4.
  15. Ueki T, Kaneda Y, Tsutsui H, et al. Hepatocyte growth factor gene therapy of liver cirrhosis in rats. Nat Med 1999; 5 : 226–30.
  16. Guillen MI, Gomez-Lechon MJ, Nakamura T, Castell JV. The hepatocyte growth factor regulates the synthesis of acute-phase proteins in human hepatocytes: divergent effect on interleukin-6-stimulated genes. Hepatology 1996; 23 : 1345–52.
  17. Moshage H. Cytokines and the hepatic acute phase response. J Pathol 1997; 181 : 257–66.
  18. Paradis V, Laurent A, Mathurin P, et al. Role of liver extracellular matrix in transcriptional and post-transcriptional regulation of apolipoprotein A-I by hepatocytes. Cell Mol Biol 1996; 42 : 525–34.
  19. Edwards AM, Lucas CM, Baddams HM. Modulation of gamma-glutamyltranspeptidase in normal rat hepatocytes in culture by cell density, epidermal growth factor and agents which alter cell differentiation. Carcinogenesis 1987; 8 : 1837–42.
  20. Poynard T, Imbert-Bismut F, Ratziu V, et al Biochemical markers of liver fibrosis in patients infected by hepatitis C virus: longitudinal validation in a randomized trial. J Viral Hepatitis 2002 (sous presse).

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.